Showing 2,281 - 2,300 results of 16,175 for search '(( significant ((level decrease) OR (greater decrease)) ) OR ( significantly increased decrease ))', query time: 0.53s Refine Results
  1. 2281

    Student model architecture. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
  2. 2282

    Configuration of the LastBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
  3. 2283

    Confusion matrix for DistilBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
  4. 2284

    ROC curve for LastBERT model. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
  5. 2285

    Sample Posts from the ADHD dataset. by Ahmed Akib Jawad Karim (20427740)

    Published 2025
    “…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
  6. 2286
  7. 2287
  8. 2288
  9. 2289
  10. 2290
  11. 2291
  12. 2292
  13. 2293
  14. 2294
  15. 2295
  16. 2296
  17. 2297
  18. 2298
  19. 2299
  20. 2300

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”